Dilated Cardiomyopathy (DCM) is a serious heart condition characterized by the enlargement of the heart chambers, specifically the left ventricle. This disorder weakens the heart muscle, impairing its ability to pump blood efficiently. As a result, the heart becomes dilated and weakened, leading to a decrease in the overall pumping function. DCM can be caused by a variety of factors, including genetic predisposition, viral infections, certain medications, and exposure to toxins. The symptoms of DCM often include fatigue, shortness of breath, swelling in the legs, and an irregular heartbeat. Timely identification plays a pivotal role in effectively managing the condition and averting potential complications.. Treatment options may include medications, lifestyle changes, and in severe cases, heart transplant. Regular medical monitoring and adherence to a heart-healthy lifestyle are essential for individuals living with Dilated Cardiomyopathy.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation